| Formulary Chapter 6: Endocrine system - Full Chapter
|
| 06.04.01.01 |
Oestrogens and HRT |
|
|
| 06.04.01.01 |
Hormone replacement therapy |
|
|
| 06.04.01.01 |
Ethinylestradiol |
|
|
| 06.04.01.01 |
Oestrogen only tablets |
|
|
| 06.04.01.01 |
Oestrogens and progestogen sequential combined therapy |
|
|
| 06.04.01.01 |
Continuous combined therapy |
|
|
| 06.04.01.01 |
Gonadomimetic |
|
|
| 06.04.01.01 |
Selective oestrogen modulator |
|
|
Bazedoxifene/Conjugated Oestrogens (Duavive®)
 
|
Non Formulary
|
|
Estradiol with progesterone continuous tablets for HRT (Angeliq®)
|
Non Formulary
|
|
Nuvelle Continous tablets
|
Non Formulary
|
|
Utrogestan® Vaginal Capsules
|
Non Formulary
|
|
Key |
 |
Restricted Drug |
 |
Unlicensed |
|
|
Link to adult BNF
|
|
|
Link to children's BNF
|
|
|
Link to SPCs
|
|
Cytotoxic Drug |
|
Controlled Drug |
|
|
High Cost Medicine |
|
Cancer Drugs Fund |
|
NHS England |
|
Homecare |
|
ICB |
|
Low carbon footprint |
|
Medium carbon footprint |
|
High carbon footprint |
|
| Status |
Description |
|
Medicines which are suitable for initiation and maintenance prescribing by primary and secondary care clinicians. These medicines should be initiated and prescribed within their licensed indications |
|
Amber Specialist Initiation: Initiation and maintenance of prescribing by Specialists and transfer to Primary Care prescribing when appropriate. This may be supported by a RICaD, annotated within the formulary entry. |
|
Amber Shared Care: Initiation and maintenance of prescribing by Specialists and transfer to Primary Care prescribing, in accordance with an ESCA, annotated within the formulary entry. |
|
Amber Specialist Recommendation: Initiation and maintenance of prescribing in Primary Care following recommendation from a specialist. |
|
Medicines for initiation and maintenance prescribing by Specialists (hospital or GPs with Special Interest) only |
|
Positive NICE TA and /or awaiting local clarification on place in therapy; Please contact your Medicines Optimisation team for more information. |
|
Non-formulary Medicines which APC/Trust DTC has actively reviewed and do not recommend for use. |
|
Check Notes as varies across the area |
|
|
